Literature DB >> 294125

Insulin and glucagon secretion in hepatic glycogenoses.

S Okada, Y Seino, H Kodama, T Yutaka, K Inui, M Ishida, H Yabuuchi, Y Seino.   

Abstract

Insulin and glucagon secretion was investigated in ten patients with hepatic glycogenosis, types I and III, in order to understand the relationship between hypoglycemia and pancreatic function. In all patients, both oral glucose tolerance and intravenous arginine infusion tests revealed hypoinsulinemia. Decreased urinary C-peptide levels with standard food intake also supported hypofunction of pancreatic beta cells. On the contrary, the normal secretion pattern of glucagon in both types indicated in the arginine loading test, intact alpha cells in the pancreas. Persistent hypoinsulinism, which is apparently an adaptation to hypoglycemia, could be an important cause of nutritional dwarfism in both types of glycogenosis. The usefulness of the measurement of urinary C-peptide, which evaluates the pancreatic function and provides management for normal body growth, is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 294125     DOI: 10.1111/j.1651-2227.1979.tb18448.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  Growth and endocrine changes in the hepatic glycogenoses.

Authors:  D B Dunger; A T Holder; J V Leonard; J Okae; M A Preece
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

2.  Difficult hGH treatment in a patient with type III glycogen storage disease.

Authors:  D Larizza; G Maggiore; D Marzani; M Maghnie; R Ciceri
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

3.  Hyperglycaemia associated with lactic acidaemia in a renal allograft recipient with type I glycogen storage disease.

Authors:  Y T Chen; J I Scheinman
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

4.  Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.

Authors:  J L Cohen; A Vinik; J Faller; I H Fox
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.